Alpha Blocker and 5-Alpha Reductase Inhibitor Prescribing Habits Among Urologists and Primary Care Physicians

    January 2019 in “ Urology Practice ”
    Kevin Chua, Gen Li, Matthew P. Rutman, Elias S. Hyams
    Studysummary This study observed that urologists are more likely than primary care physicians to prescribe a variety of alpha blockers and newer medications, indicating a broader awareness of treatment options for benign prostate enlargement.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on auajournals.org →
    Discuss this study in the Community →

    Research cited in this study 1

    1. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003

    Related research 1

    1. Key Clinical Trials in Benign Prostatic Hyperplasia 2002